<DOC>
	<DOCNO>NCT00216268</DOCNO>
	<brief_summary>Japanese encephalitis single large cause viral encephalitis world today . It occur yearly post monsoon outbreak Uttar Pradesh part India south east Asia . There presently antiviral drug proven benefit illness treatment mostly supportive . The drug Ribavirin already market use indication . It find useful West Nile encephalitis various hemorrhagic fever cause related arbovirus . This double blind placebo Ribavirin Japanese encephalitis . To best knowledge , first trial world . The study hypothesis child treat ribavirin different get placebo term mortality , length hospital stay , day return consciousness oral feed , day become afebrile convulsion free 3 month sequela rate .</brief_summary>
	<brief_title>Treatment Japanese Encephalitis</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Child 6 month 12 year age Acute febrile encephalopathy Positive IgM ELISA test Japanese encephalitis serum Consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>